iris has evolved

this is Pebble

portable | molecular | real-time | unique
The innovative molecular diagnostic device for rapid testing at the Point-of-Care.
pebble device


Technology description

Pebble is a compact device for performing real-time colorimetric LAMP (qcLAMP). Pebble was created using three-dimensional (3D) additive manufacturing technology and operates via an Android application. The device can be used to extract rapidly quantitative information at a wide dynamic range of RNA or DNA template. Detection can occur from purified nucleic acids or directly from crude samples (swabs, saliva and biopsy tissue).

“Papadakis, Real-time colorimetric LAMP methodology for quantitative nucleic acids detection at the point-of-care, BioRxiv 2020”

Read here

validated for :

and Flu A

and CYP2C19*2

Food &

key features

Sample-to-answer in 15 to 30 min




Low power consumption

Smartphone controlled


Affordable to all


The company behind Pebble

Our vision

Our vision is to become an innovation leader in the field of molecular diagnostics and grow into an international company with significant global presence.

Our mission

Our mission is to offer portable diagnostic devices to every potential end-user, regardless of financial status, geographical location and training. Doctors, healthcare providers and patients in both the developed and developing countries will benefit equally from our technology, which intends to alleviate personal suffering and control disease outbreaks.

meet our team

George Papadakis, PhD

Chief Executive Officer

Alexandros Pantazis, PhD

Product Development Manager

Nikolaos Fikas, MSc

Head of Software and Electronics

Sergios Katsaros, MBA

Head of Commercial and Finance

Stella Chatziioannidou, MSc

Biotechnology R&D Specialist

Dimitra Founta, MSc

Product Development Specialist

Eleni Makraki, PhD

Head Of Compliance - Quality Assurance Manager

Angelina Barla, LL.M

Legal Advisor

Electra Gizeli, Prof.



BIOPIX-T receives the ISO/IEC 27001:2013 certification and expands its ISO 13485:2016

BIOPIX-T ( ) is pleased to announce that its information security management system (ISMS) has been certified as per ISO/IEC 27001:2013 by DQS Hellas. Moreover, BIOPIX-T successfully audited for the extension of the scope of its ISO 13485:2016, also by DQS Hellas, to additionally include the “Technical Support” and also cover its new manufacturing premises. Our new certification as per ISO/IEC 27001:2013 confirms […]

read more

Eleven invests in the Greek biotech company BIOPIX-T

After the initial investment from, we are exited to be also included in the portfolio of Eleven Ventures, further broadening the institutional support we receive and our geographical footprint! On the investment in BIOPIX-T Valeri Petrov, Partner at Eleven Ventures explains: “BIOPIX-T is our first investment in Greece and the company fits perfectly in one of our […]

read more


BIOPIX-T ( ) is pleased to announce that its quality management system (QMS) has been successfully certified as per ISO 13485:2016 requirements by DQS Hellas, with scope “Design and Development, Production, Storage and Distribution of nucleic acid amplification kits (COV19 qc LAMP kit and Flu A qc LAMP kit) and instruments (Pebble qc LAMP platform)”.  Our ISO 13485:2016 certification serves our mission to offer safe portable In-Vitro diagnostic medical devices […]

read more

10 promising Greece-based startups to watch in 2021!

BIOPIX-T was included in the EU startups list of the 10 promising startups from Greece to watch in 2021! We are among the 10 ‘up and coming’ local startups making a name for themselves, which were founded in the last 1-3 years, show promising signs, landed funding in the last year and are growing their teams […]

read more
more news